LATIN AMERICA ONCOLOGY DEVICE MARKET ANALYSIS

Latin America Oncology Device Market, By Chemotherapy Administration (Gravity Chemotherapy Administration, Syringe Chemotherapy Administration, Pump Chemotherapy Administration, and Others), By Accessories and Consumables (Infusion Sets, Venous Access (Ports, and Needles), Catheter (Central venous catheter(CVC), and Peripherally inserted central catheter(PICC)), Needle Connectors, Syringe Filters, and Software), By Age Group (Pediatric (Infant (from birth to 1 year), Children ( 4 to 10 years), and Teenager/Adolescent (11 to 19 years) and Adults), By End User (Private Hospitals/Clinics (General Hospitals with Oncology Centers, Specialized Hospitals, and Specialized Clinics), Public Hospitals/ Clinics (General Hospitals with Oncology Centers, Specialized Hospitals, and Specialized Clinics), and Others (Homecare Settings, and Research Institutes)), and By Country (Brazil, Mexico, and Chile) -

Published In : Jul 2023
Code : CMI4199
Pages :175
Formats :
Excel and PDF
Industry : Medical Devices

Market Challenges And Opportunities

Commercial tie-ups and acquisitions by key players
Increasing awareness about the cervical cancer diagnosis

Lack of spousal and or family support

Latin America Oncology Device Market: Restraints

Lack of spousal and or family support

Lack of spousal and or family support is expected to hinder the market growth over the forecast period. So, rise in the awareness campaigns can ne imitated to avoid this unawareness. For instance, in December 2022 according to an article published in the Journal of Biomed Central, lack of spousal and or family support were key barriers, and these may be driven by misconceptions about cancer and traditional, cultural, or religious beliefs about pelvic examination and cancers, and this has also been reported in high income countries. Overlapping with cultural/traditional and religious barriers were other social factors, including misconceptions and stigmatization of screening and cancer, largely shaped by gender norms.